SCHEMBL25829772

SCHEMBL25829772

Bc1c(B)c(B)c(-c2c3ccccc3c(-c3ccc4ccc5ccc(-c6c7ccccc7c(-c7ccccc7)c7ccccc67)cc5c4c3)c3ccccc23)c(B)c1B

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 9/20 0.38
ESR2 Q92731 8/20 0.38
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 3/20 0.36
CYP1B1 Q16678 2/20 0.36
HIF1A Q16665 1/20 0.36
ALOX5 P09917 1/20 0.35
ACHE P22303 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
KDM4E B2RXH2 2/20 0.34
MAPT P10636 2/20 0.34
MAPK1 P28482 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2B6 P20813 2/20 0.33
CYP2C19 P33261 2/20 0.33
HSD17B1 P14061 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25829298 0.95 ALDH1A1 (0.40) ESR1ESR2ALDH1A1HSD17B10CYP1B1
SCHEMBL21480001 0.91 ALDH1A1 (0.47) ESR1ESR2ALDH1A1HSD17B10CYP1B1
SCHEMBL25829126 0.87 ALDH1A1 (0.46) ESR1ESR2ALDH1A1HSD17B10CYP1B1
SCHEMBL24178711 0.86 ESR1 (0.46) ESR1ESR2ALOX5CYP1A2CYP3A4
SCHEMBL25829612 0.85 CYP2A6 (0.36) ESR1ESR2ALDH1A1HSD17B10CYP1B1
SCHEMBL2848482 0.83 ALDH1A1 (0.54) ESR1ESR2ALDH1A1HSD17B10CYP1B1
SCHEMBL26566443 0.83 ALOX5 (0.41) ALDH1A1HSD17B10CYP1B1HIF1AALOX5
SCHEMBL25829463 0.82 ESR1 (0.36) ESR1ESR2ALDH1A1HSD17B10CYP1B1
SCHEMBL22868352 0.82 ACHE (0.36) ESR1ESR2ALDH1A1HSD17B10ALOX5
SCHEMBL23056742 0.82 ACHE (0.36) ESR1ESR2ALDH1A1HSD17B10ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230225195-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PERFORMANCE MATERIALS GERMANY GMBH (DE) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230225195-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES H1-0, H1-2, H1-4 ESR1 144/4885ESR2 913/4885ALDH1A1 157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.